Novatek Microelectronics Earnings Call Transcripts
Fiscal Year 2026
-
Q1 2026 saw modest sequential growth in revenue and margins, led by SoC and large driver ICs, but year-over-year declines persisted. Q2 is projected to deliver strong double-digit growth, with all segments contributing and new high-end products expected to drive full-year gains.
Fiscal Year 2025
-
Q4 revenue and profit declined year-over-year but margins improved sequentially, exceeding guidance. 2026 growth is expected from new AI-enabled SoC and OLED products, though rising memory and gold costs and supply constraints pose risks.
-
Q3 revenue and profit declined year-over-year but met guidance, with gross margin stable sequentially. Q4 is expected to be seasonally weaker, but new product launches and AI-enabled solutions are set to drive growth in 2026. Cash declined due to dividends, and ESG ratings improved.
-
Q2 revenue grew 4% year over year but declined 4% sequentially, with margins pressured by FX and rising costs. Q3 guidance points to further revenue and margin declines, while OLED TDDI shipments are set to exceed 10 million units in 2025.
-
Q1 saw strong revenue and margin growth, with all key metrics at the high end of guidance. Q2 guidance is stable, with continued focus on cost control, product innovation, and monitoring FX and tariff risks. Dividend payout remains robust and market share in key segments is expanding.
Fiscal Year 2024
-
Q4 revenue and profit declined year-over-year but exceeded guidance, with gross margin at the high end of expectations. Q1 2025 is guided to grow sequentially, driven by China subsidies and tariff-related demand, while margins are expected to remain stable. Dividend payout and strong cash position are maintained.
-
Q3 revenue and gross profit rose sequentially but declined year-over-year, with margins pressured by product mix and rising costs. Q4 revenue and margins are expected to decline due to weak consumer electronics demand, but 2025 growth is anticipated from AI-related products and new launches.